Luciano, Juan V <br/><br/>
Cost-Utility of Group Acceptance and Commitment Therapy for Fibromyalgia Versus Recommended Drugs: An Economic Analysis Alongside a 6-Month Randomized Controlled Trial Conducted in Spain (EFFIGACT Study).  [electronic resource] 

 -  The journal of pain  07 2017 
 - 868-880 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1528-8447 
<br/><br/><label>Standard No.: </label>10.1016/j.jpain.2017.03.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acceptance and Commitment Therapy--economics<br/>Adult<br/>Analgesics--administration & dosage<br/>Cost-Benefit Analysis<br/>Duloxetine Hydrochloride--economics<br/>Female<br/>Fibromyalgia--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Outcome Assessment, Health Care--economics<br/>Pregabalin--economics<br/>Psychotherapy, Group--economics<br/>Spain